RDNT Stock Analysis: Buy, Sell, or Hold?
RDNT - RadNet, Inc. Common Stock
$55.77
-0.38 (-0.68%)
▼
5d:
-9.67%
30d:
-20.11%
90d:
-23.76%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
RDNT is down 5.9% this week, but smart money is accumulating calls. Top strike: $65 2026-06-18 with 2 OI. Call ratio: 100% View Scanner →
Strength: 8.0/10
Get Alerted When RDNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RDNT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: RDNT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$49.17
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$30.53
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RDNT is currently trading at $55.77, which is considered oversold relative to its 30-day fair value range of $59.44 to $69.78. From a valuation perspective, the stock is trading at a discount (Forward PE: 55.6) compared to its historical average (86.4). Remarkably, the market is currently pricing in an annual earnings decline of 13.7% over the next few years. This pessimistic expectation contrasts with the company's recent 75.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, RDNT is in a strong downtrend. The price is currently testing key support at $55.88. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RDNT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $92.38 (+64.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RDNT is in a strong downtrend. The price is currently testing key support at $55.88. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RDNT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $92.38 (+64.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$59.44 -
$69.78
Company Quality Score
55/100
(HOLD)
Options IV Signal
43th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding RDNT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 43th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.5% below Wall St target ($92.38)
- CAUTION: 5-day price weakness (-9.7%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$59.44 -
$69.78
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$4.39
(7.9%)
Support & Resistance Levels
Support Level
$55.89
Resistance Level
$66.20
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
55.59
Wall Street Target
$92.38
(+64.5%)
Revenue Growth (YoY)
14.8%
Earnings Growth (YoY)
75.0%
Profit Margin
-0.9%
Valuation Discount vs History
-13.7% cheaper
PE vs Historical
55.6 vs 86.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.7%
(market-implied from PE analysis)
1-Year Target
$50.53
(-10%)
2-Year Target
$45.48
(-19%)
3-Year Target
$40.93
(-27%)
3-Yr Target (if PE normalizes)
(PE: 56→86)
$63.62
(+13%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 55.6, Growth: 74.7%)
$189.51
(+238%)
Base:
(SPY PE: 22.4, Growth: 74.7%)
$76.36
(+36%)
Bear:
(PE: 19.0, Growth: 74.7%)
$64.90
(+16%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 55.6 to 86.4
Stabilization Target:
$87.26
(+55.4%)
PE Expansion Potential:
+55.4%
Share & Embed Analysis
Last updated: March 30, 2026 3:17 PM ET
Data refreshes hourly during market hours. Next update: 4:17 PM
Data refreshes hourly during market hours. Next update: 4:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RDNT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Alma Gregory Sorensen
SELL
15000 shares
2026-03-18
Mital Patel
SELL
15080 shares
2025-11-19
Mital Patel
SELL
9920 shares
2025-11-18
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 60 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 61 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 54 HOLD |
Advanced RDNT Option Strategies
Professional options setups generated by AI based on today's RDNT price and gamma walls.
